Vaccination with GM2-KLH-QS21 does not improve outcome of melanomas patients in EORTC study
Results of an EORTC study published in the Journal of Clinical Oncology show that vaccination with GM2/KLH-QS-21 does not benefit patients with stage II melanoma. Vaccination with GM2/KLH-QS-21 stimulates the production of ...
Sep 13, 2013
0
0